TCL Archive NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems October 13, 1978
TCL Archive Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer December 27, 2002
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Applications Pour In for construction Grants; Three Compete For Mouse Laboratory June 1, 1990
